Frequent methylation (55 %) of SFRP2 was also observed, but its relationship to glioma aggressiveness was not as straightforward as in the case of SFRP1. The methylation of SFRP2 did not correlate with either tumor grade or survival time. The gene discussed is SFRP1; the disease is glioma.